| Primary |
| Benign Prostatic Hyperplasia |
47.8% |
| Hypertension |
21.9% |
| Drug Use For Unknown Indication |
6.7% |
| Product Used For Unknown Indication |
6.4% |
| Prostatic Disorder |
2.3% |
| Prophylaxis |
1.8% |
| Cardiovascular Event Prophylaxis |
1.3% |
| Hyperuricaemia |
1.3% |
| Hypothyroidism |
1.3% |
| Renal Failure Chronic |
1.3% |
| Urinary Retention |
1.3% |
| Coronary Artery Disease |
1.0% |
| Prostatomegaly |
1.0% |
| Atrial Fibrillation |
0.8% |
| Dysuria |
0.8% |
| Pollakiuria |
0.8% |
| Schizophrenia, Paranoid Type |
0.8% |
| Breast Cancer |
0.5% |
| Breast Operation |
0.5% |
| Constipation |
0.5% |
|
| Syncope |
39.1% |
| Hypotension |
18.8% |
| Orthostatic Hypotension |
11.8% |
| Dizziness |
10.0% |
| Presyncope |
3.0% |
| Vomiting |
1.8% |
| Rash |
1.5% |
| Vision Blurred |
1.5% |
| Visual Field Defect |
1.5% |
| Angina Pectoris |
1.1% |
| Blood Pressure Decreased |
1.1% |
| Bradycardia |
1.1% |
| Fall |
1.1% |
| Loss Of Consciousness |
1.1% |
| Priapism |
1.1% |
| Product Substitution Issue |
1.1% |
| Unresponsive To Stimuli |
1.1% |
| Autoimmune Thrombocytopenia |
0.7% |
| Breast Pain |
0.7% |
| Completed Suicide |
0.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
52.5% |
| Hypertension |
13.7% |
| Product Used For Unknown Indication |
11.2% |
| Benign Prostatic Hyperplasia |
7.9% |
| Depression |
1.7% |
| Atrial Fibrillation |
1.2% |
| Hyperlipidaemia |
1.2% |
| Multiple Myeloma |
1.2% |
| Prostatomegaly |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Diabetes Mellitus |
1.0% |
| Hyperhidrosis |
1.0% |
| Cardiac Failure Congestive |
0.8% |
| Colon Cancer |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Bipolar Disorder |
0.6% |
| Cardiac Disorder |
0.6% |
| Coronary Artery Disease |
0.6% |
| Hypothyroidism |
0.6% |
| Pollakiuria |
0.6% |
|
| Syncope |
26.1% |
| Pancreatic Carcinoma |
13.9% |
| Hypotension |
10.4% |
| Completed Suicide |
8.7% |
| Rhabdomyolysis |
5.2% |
| Vision Blurred |
4.3% |
| Dizziness |
3.5% |
| Abdominal Pain |
2.6% |
| Drug Ineffective |
2.6% |
| Fatigue |
2.6% |
| Loss Of Consciousness |
2.6% |
| Orthostatic Hypotension |
2.6% |
| Presyncope |
2.6% |
| Blood Pressure Inadequately Controlled |
1.7% |
| Cellulitis |
1.7% |
| Constipation |
1.7% |
| Fall |
1.7% |
| Knee Arthroplasty |
1.7% |
| Multiple Sclerosis Relapse |
1.7% |
| Renal Failure Acute |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.6% |
| Drug Use For Unknown Indication |
19.5% |
| Hypertension |
13.2% |
| Diabetes Mellitus |
4.1% |
| Pain |
3.7% |
| Multiple Myeloma |
3.1% |
| Atrial Fibrillation |
3.1% |
| Benign Prostatic Hyperplasia |
3.1% |
| Blood Cholesterol Increased |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Depression |
2.6% |
| Blood Pressure |
2.5% |
| Cardiac Disorder |
2.5% |
| Prophylaxis |
2.2% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Prostatic Disorder |
1.6% |
| Prostate Cancer |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| Insomnia |
1.3% |
| Rheumatoid Arthritis |
1.3% |
|
| Vomiting |
10.9% |
| Drug Ineffective |
9.2% |
| Weight Decreased |
8.3% |
| Weight Increased |
6.2% |
| Death |
5.8% |
| Vision Blurred |
5.1% |
| White Blood Cell Count Decreased |
4.9% |
| Pruritus |
4.6% |
| Urinary Tract Infection |
4.6% |
| Dyspnoea |
4.3% |
| Flushing |
4.0% |
| Nausea |
4.0% |
| Syncope |
3.8% |
| Pneumonia |
3.5% |
| Pyrexia |
3.5% |
| Rhabdomyolysis |
3.5% |
| Thrombocytopenia |
3.5% |
| Dizziness |
3.4% |
| Rash |
3.4% |
| Hypotension |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
60.0% |
| Erectile Dysfunction |
10.0% |
| Atrial Fibrillation |
5.0% |
| Benign Prostatic Hyperplasia |
5.0% |
| Hypertension |
5.0% |
| Ischaemic Heart Disease Prophylaxis |
5.0% |
| Parkinson's Disease |
5.0% |
| Prostatic Disorder |
5.0% |
|
| Heart Rate Increased |
25.0% |
| Prostatic Disorder |
25.0% |
| Sinus Bradycardia |
25.0% |
| Syncope |
25.0% |
|
